Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (2018 - 2025)

Health Catalyst (HCAT) has disclosed Shares Outstanding for 8 consecutive years, with $70.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 16.24% year-over-year to $70.7 million, compared with a TTM value of $70.7 million through Sep 2025, up 16.24%, and an annual FY2024 reading of $64.0 million, up 9.42% over the prior year.
  • Shares Outstanding was $70.7 million for Q3 2025 at Health Catalyst, up from $70.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $70.7 million in Q3 2025 and bottomed at $44.3 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $57.4 million, with a median of $55.8 million recorded in 2022.
  • The sharpest move saw Shares Outstanding rose 22.78% in 2021, then increased 1.92% in 2023.
  • Year by year, Shares Outstanding stood at $52.6 million in 2021, then rose by 5.97% to $55.8 million in 2022, then grew by 4.96% to $58.5 million in 2023, then increased by 9.42% to $64.0 million in 2024, then grew by 10.44% to $70.7 million in 2025.
  • Business Quant data shows Shares Outstanding for HCAT at $70.7 million in Q3 2025, $70.4 million in Q2 2025, and $69.6 million in Q1 2025.